A substantial amount of data has revealed that SOX9 contributes to chemoresistance in various solid tumour models, including gastric cancer,23, 36 hepatocellular carcinoma,37 pancreatic cancer38 and glioma.39 This evidence concerns the gene SOX9 and hepatocellular carcinoma.